These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35831326)

  • 1. Predictive factors for massive hemorrhage in women with retained products of conception: a prospective study.
    Sonehara R; Nakamura T; Iwase A; Nishida K; Takikawa S; Murakami M; Yoshita S; Muraoka A; Miyake N; Nakanishi N; Osuka S; Goto M; Kajiyama H
    Sci Rep; 2022 Jul; 12(1):11859. PubMed ID: 35831326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RPOC long axis is a simple indicator for predicting the need of invasive strategies for secondary postpartum hemorrhage in either post-abortion or post-partum women: a retrospective case control study.
    Kobayashi M; Nakagawa S; Kawanishi Y; Masuda T; Maenaka T; Toda A; Miyake T; Hiramatsu K; Miyoshi A; Mimura K; Kimura T; Endo M; Kimura T
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):653. PubMed ID: 34560846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retained products of conception (RPOC) following delivery without placenta previa: Which patients with RPOC show postpartum hemorrhage?
    Takahashi H; Tanaka H; Osuga Y; Miura K; Saito S; Sato S; Sugawara J; Ide S; Koh I; Yamauchi K; Okuyama A; Okuno K; Kuwata T; Fujieda S; Ikeda T
    Placenta; 2022 Jun; 124():12-17. PubMed ID: 35580405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of retained products of conception in placenta previa: a retrospective analysis.
    Kishimoto N; Miyamoto M; Imauji A; Takada M; Nishitani S; Tanabe R; Ito T; Hada T; Otsuka Y; Takano M
    BMC Pregnancy Childbirth; 2023 Jun; 23(1):481. PubMed ID: 37391723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of clinical characteristics and maternal outcomes of women with pathologically confirmed postpartum retained placental fragments.
    Rottenstreich M; Atia O; Greifner N; Rotem R; Grisaru-Granovsky S; Vernea F; Reichman O; Y Sela H
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7322-7329. PubMed ID: 34219575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Prediction of Retained Products of Conception: Combining Obstetric History and Ultrasound for Improved Accuracy in Severe Postpartum Hemorrhage.
    Kurakazu M; Kurakazu M; Kiyoshima C; Shigekawa K; Hirakawa T; Yoshikawa K; Ito T; Urushiyama D; Miyata K; Yotsumoto F
    Cureus; 2024 Feb; 16(2):e53651. PubMed ID: 38449994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Hypervascular Retained Products of Conception With Massive Bleeding.
    Shimada T; Wakimoto Y; Kamihigashi M; Tanaka H; Shibahara H
    Cureus; 2023 Sep; 15(9):e45952. PubMed ID: 37885542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manual removal of the placenta and postpartum hemorrhage: A multicenter retrospective study.
    Fujita K; Ushida T; Imai K; Nakano-Kobayashi T; Iitani Y; Matsuo S; Yoshida S; Yamashita M; Kajiyama H; Kotani T
    J Obstet Gynaecol Res; 2021 Nov; 47(11):3867-3874. PubMed ID: 34482579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound for diagnosis of postpartum retained products of conception-How accurate we are?
    Yagur Y; Jurman L; Weitzner O; Arbib N; Markovitch O; Klein Z; Daykan Y; Schonman R
    BMC Pregnancy Childbirth; 2023 Aug; 23(1):572. PubMed ID: 37563560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postpartum retained products of conception: Retrospective analysis of the association with third stage of labor placental complications.
    Smorgick N; Ayashi N; Levinsohn-Tavor O; Wiener Y; Betser M; Maymon R
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():108-111. PubMed ID: 30682599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative management of retained products of conception in the normal placental position: A retrospective observational study.
    Takahashi H; Ohhashi M; Baba Y; Nagayama S; Ogoyama M; Horie K; Suzuki H; Usui R; Ohkuchi A; Matsubara S
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():87-92. PubMed ID: 31238204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic, histologic, and imaging features of retained products of conception.
    Sellmyer MA; Desser TS; Maturen KE; Jeffrey RB; Kamaya A
    Radiographics; 2013 May; 33(3):781-96. PubMed ID: 23674774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic evaluation of retained products of conception within 48 h following delivery: a retrospective cohort study.
    Ashkar Majadla N; Abu Shqara R; Haj S; Sgayer I; Ghanem N; Lowenstein L; Odeh M
    Arch Gynecol Obstet; 2024 Aug; ():. PubMed ID: 39133292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Office Operative Hysteroscopy for the Management of Retained Products of Conception.
    Mohr-Sasson A; Gur T; Meyer R; Mashiach R; Stockheim D
    Reprod Sci; 2022 Mar; 29(3):761-767. PubMed ID: 35020188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of clinical and ultrasound findings in the diagnosis of retained products of conception.
    Abbasi S; Jamal A; Eslamian L; Marsousi V
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):704-7. PubMed ID: 18792059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonographic vascularity assessment for predicting future severe hemorrhage in retained products of conception after second-trimester abortion.
    Akiba N; Iriyama T; Nakayama T; Seyama T; Sayama S; Kumasawa K; Komatsu A; Yabe S; Nagamatsu T; Osuga Y; Fujii T
    J Matern Fetal Neonatal Med; 2021 Feb; 34(4):562-568. PubMed ID: 31006292
    [No Abstract]   [Full Text] [Related]  

  • 17. Retained Products of Conception Fed by the Inferior Mesenteric Artery: A Case Report.
    Goto Y; Kanno Y; Hayashi M; Mitsuzuka K; Sekiguchi T; Suzuki T; Ishimoto H
    Tokai J Exp Clin Med; 2020 Sep; 45(3):131-135. PubMed ID: 32901901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing patients with suspected postpartum retained products of conception using a novel sonographic classification.
    Levinsohn-Tavor O; Sharon NZ; Feldman N; Svirsky R; Smorgick N; Nir-Yoffe A; Maymon R
    Acta Radiol; 2022 Mar; 63(3):410-415. PubMed ID: 33517665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine Artery Embolization for Retained Products of Conception with Marked Vascularity: A Safe and Efficient First-Line Treatment.
    Bazeries P; Paisant-Thouveny F; Yahya S; Bouvier A; Nedelcu C; Boussion F; Sentilhes L; Willoteaux S; Aubé C
    Cardiovasc Intervent Radiol; 2017 Apr; 40(4):520-529. PubMed ID: 28004170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of retained products of conception: A prospective observational study.
    Schulte RL; Fox R; Anderson J; Young N; Davis L; Saxton V; Mooney SS
    Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():153-158. PubMed ID: 37120911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.